Pain Neuroscience Education in Chronic Musculoskeletal Pain
Pain Neuroscience Education as a Complement to Physiotherapy in Patients With Chronic Musculoskeletal Pain: a Non-randomized Controlled Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
Chronic musculoskeletal pain (CMP) is highly prevalent, disabling and with high socio-economic costs, with many negative effects on quality of life. CMP affects the ability to perform work, social, recreational and domestic tasks by changing the mood and concentration of this population that suffers. In a study carried out in 2010, 17% of the Spanish population had experienced pain in the last month and according to the severity of symptoms 12% felt severe , 64% moderate and 24% mild pain. In this same study it is specified that 61% was due to back pain, 29% due to neck pain and 23% due to shoulder pain. Pain neuroscience education (PNE) has been shown as an effective treatment strategy in increasing knowledge and understanding of neurobiology, neurophysiology and pain processing, modifying beliefs about it, improving patient skills and encouraging to the accomplishment of physical and social activities in different chronic pathologies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2017
CompletedFirst Posted
Study publicly available on registry
April 4, 2017
CompletedStudy Start
First participant enrolled
April 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2020
CompletedJune 4, 2020
June 1, 2020
1.8 years
March 22, 2017
June 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline self-efficacy at 1 and 4 months
This outcome will be measured with the Chronic Pain Self-Efficacy Scale
1 and 4 months
Secondary Outcomes (2)
Change from Baseline pain and pain interference at 1 and 4 months
1 and 4 months
Change from Baseline analgesic medication at 1 and 4 months
1 and 4 months
Other Outcomes (1)
Change from Baseline pain knowledge at 1 and 4 months
1 and 4 months
Study Arms (2)
PNE+Physiotherapy
EXPERIMENTALPain neuroscience education (PNE) can be defined as an educational session or sessions describing the neurobiology and neurophysiology of pain, and pain processing by the nervous system. It will be applied one time (at baseline). Physiotherapy includes kinesitherapy and exercises.
Physiotherapy
ACTIVE COMPARATORPhysiotherapy includes kinesitherapy and exercises.
Interventions
Physiotherapy cover kinesitherapy and exercises techniques. Besides that it will be covered the understanding and acknowledgement about how pain is processed.
Eligibility Criteria
You may qualify if:
- Age between 18-65 years
- Chronic Musculoskeletal Pain according to the ACCTION-APS Pain Taxonomy (AAPT), included chronic axial musculoskeletal low back pain
You may not qualify if:
- Chronic postoperative musculoskeletal pain and chronic musculoskeletal pain related to a traumatic injury six months before the beginning of the trial
- Inability to provide written informed consent and/or complete questionnaires in Spanish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Malagalead
- Fundación Pública Andaluza Progreso y Saludcollaborator
Study Sites (1)
UGC Las Lagunas
Mijas Costa, Málaga, 29650, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alejandro Luque Suarez, PhD
University of Malaga
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
March 22, 2017
First Posted
April 4, 2017
Study Start
April 4, 2018
Primary Completion
January 22, 2020
Study Completion
January 22, 2020
Last Updated
June 4, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share